Case number 1:22-cv-00818
Astellas Pharma Inc. et al v. Sawai Pharmaceutical Co. Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 29, 2023 | 25 | STIPULATION OF DISMISSAL (CASE CLOSED). Signed by Judge Joseph F. Bataillon on 6/29/2023. (nmg) (Entered: 06/29/2023) (1) |
| Feb 6, 2023 | 24 | STIPULATION of Dismissal Without Prejudice as to Defendants Sawai Pharmaceutical Co., Ltd. and Sawai USA, Inc. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 02/06/2023) (2) |
| Nov 4, 2022 | 23 | SO ORDERED, re 22 Stipulation filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc.. (Case stayed) Signed by Judge Christopher J. Burke on 11/04/2022. (srs) (Entered: 11/04/2022) (0) |
| Nov 3, 2022 | 22 | STIPULATION and [Proposed] Order to Stay by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 11/03/2022) (3) |
| Oct 28, 2022 | 21 | SO ORDERED, re 20 STIPULATION TO EXTEND TIME to submit (i) a copy of Judge Burkes Case Management Checklist, (ii) a Proposed Scheduling Order, and (iii) a joint letter to November 3, 2022 filed by Sawai Pharmaceutical Co. Ltd., Sawai USA Inc. Ordered by Judge Christopher J. Burke on 10/28/2022. (srs) (Entered: 10/28/2022) (0) |
| Oct 27, 2022 | 20 | STIPULATION TO EXTEND TIME to submit (i) a copy of Judge Burkes Case Management Checklist, (ii) a Proposed Scheduling Order, and (iii) a joint letter to November 3, 2022 - filed by Sawai Pharmaceutical Co. Ltd., Sawai USA Inc.. (Gattuso, Dominick) (Entered: 10/27/2022) (2) |
| Oct 21, 2022 | 19 | SO ORDERED, re 18 STIPULATION TO EXTEND TIME the deadlines set forth in the Court's August 18, 2022 Oral Order (D.I. 15 ) requiring the parties to submit (i) a copy of Judge Burke's Case Management Checklist, (ii) a Proposed Scheduling Order, and (iii) a joint filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Signed by Judge Christopher J. Burke on 10/21/2022. (srs) (Entered: 10/21/2022) (0) |
| Oct 20, 2022 | 18 | STIPULATION TO EXTEND TIME the deadlines set forth in the Court's August 18, 2022 Oral Order (D.I. 15) requiring the parties to submit (i) a copy of Judge Burke's Case Management Checklist, (ii) a Proposed Scheduling Order, and (iii) a joint letter to October 27, 2022 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 10/20/2022) (2) |
| Sep 30, 2022 | 17 | STIPULATION TO EXTEND TIME deadline for the parties to submit (i) a copy of Judge Burkes Case Management Checklist, (ii) a Proposed Scheduling Order, and (iii) a joint letter to October 20, 2022 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 09/30/2022) (2) |
| Sep 13, 2022 | 16 | STIPULATION TO EXTEND TIME for the deadlines set forth in the Court's August 18, 2022 Oral Order (D.I. 15) requiring the parties to submit (i) a copy of Judge Burke's Case Management Checklist, (ii) a Proposed Scheduling Order, and (iii) a joint letter to October 3, 2022 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 09/13/2022) (2) |
| Aug 18, 2022 | 15 | ORAL ORDER: IT IS HEREBY ORDERED that the parties shall meet and confer and discuss, in person and/or by telephone, each of the matters listed on Judge Burke's Case Management Checklist (Checklist). By no later than 30 days from todays date, the parties shall jointly file the following: (i) a copy of the Checklist, indicating the names of Lead Counsel and Delaware Counsel for each party; (ii) a proposed Scheduling Order, which is consistent with Judge Burke's "Rule 16 Scheduling Order - Patent"; and (iii) a letter, not to exceed three pages, that contains the following: (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order, and (c) a list of the three most significant topics (other than Scheduling Order disputes) discussed during the parties review of the Checklist items, along with a brief description as to what was discussed as to those topics. Thereafter, the Court may schedule a Case Management Conference/Rule 16 Scheduling Conference to be held with Judge Burke. The Checklist and Scheduling Order can be found on Judge Burke's portion of the District Court's website. Ordered by Judge Christopher J. Burke on 8/18/2022. (dlb) (Entered: 08/18/2022) (0) |
| Aug 9, 2022 | 14 | ANSWER to 12 Answer to Complaint, Counterclaim by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Silver, Daniel) (Entered: 08/09/2022) (6) |
| Jul 19, 2022 | 13 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sawai Group Holdings Ltd. for Sawai Pharmaceutical Co. Ltd., Sawai USA Inc. filed by Sawai Pharmaceutical Co. Ltd., Sawai USA Inc.. (Gattuso, Dominick) |
| Jul 19, 2022 | 12 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, with Jury Demand Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Sawai USA Inc., Sawai Pharmaceutical Co. Ltd..(Gattuso, Dominick) |
| Jul 15, 2022 | 9 | Exhibits A - B (10) |
| Jul 15, 2022 | 10 | Main Document (2) Docket Text: DECLARATION of Service on Sawai Pharmaceutical Co., Ltd. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # (1) Exhibits A - B)(Silver, Daniel) |
| Jul 15, 2022 | 10 | Exhibits A - B (10) |
| Jul 15, 2022 | 11 | Main Document (2) Docket Text: DECLARATION of Service on Sawai Pharmaceutical Co., Ltd. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # (1) Exhibits A - B)(Silver, Daniel) |
| Jul 15, 2022 | 11 | Exhibits A - B (10) |
| Jul 15, 2022 | 9 | Main Document (2) Docket Text: DECLARATION of Service on Sawai USA, Inc. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # (1) Exhibits A - B)(Silver, Daniel) |
| Jul 15, 2022 | 8 | Exhibits A - B (10) |
| Jul 15, 2022 | 8 | Main Document (2) Docket Text: DECLARATION of Service on Sawai USA, Inc. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # (1) Exhibits A - B)(Silver, Daniel) |
| Jun 29, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER - Pursuant to the filing of this case, the Court issues the following order: Magistrate Judge Burke shall issue a scheduling order when appropriate. Magistrate Judge Burke shall handle all nondispositive matters on all issues, except for Daubert motions, Markman hearings, and pretrial motions in limine. The parties have the right to file an appeal of the magistrate judge's order, and the same shall be decided by the undersigned. The magistrate judge shall likewise handle all discovery matters, scheduling, and pretrial conferences. If the parties believe the magistrate judge has a conflict of interest with this case, the parties shall so notify the Court. IT IS SO ORDERED. Signed by Judge Joseph F. Bataillon on 06/29/2022. (AEV) |
| Jun 22, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Joseph F. Bataillon of the United States District Court for the District of Nebraska, due to related cases. Please include the initials of the Judge (JFB) after the case number on all documents filed. (rjb) |
| Jun 17, 2022 | 1 | Complaint* (1) |
| Jun 17, 2022 | 6 | Summons Issued (8) Docket Text: Summons Issued as to Sawai Pharmaceutical Co. Ltd. on 6/17/2022; Sawai USA Inc. on 6/17/2022. (srs) |
| Jun 17, 2022 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas B.V. for Astellas Ireland Co., Ltd.; Corporate Parent Astellas US Holding, Inc. for Astellas Pharma Global Development, Inc. filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. (srs) |
| Jun 17, 2022 | 4 | Patent/Trademark Report (1) |
| Jun 17, 2022 | 4 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,346,532 ; 7,342,117 ; 7,982,049 ; 8,835,474 ; 10,842,780 and RE44,872. (srs) (Attachment(s) # (1) Patent/Trademark Report) (srs). |
| Jun 17, 2022 | 3 | ANDA Form (3) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than May 24, 2022. Date of Expiration of Patent: See Attached. Thirty Month Stay Deadline: No Earlier than November 24, 2024. (srs) |
| Jun 17, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs) |
| Jun 17, 2022 | 1 | Civil Cover Sheet (3) |
| Jun 17, 2022 | 1 | Exhibit A-F (121) |
| Jun 17, 2022 | 1 | Main Document (27) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Sawai Pharmaceutical Co. Ltd., Sawai USA Inc. ( Filing fee $ 402, receipt number ADEDC-3898570.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. (Attachments: # (1) Exhibit A-F, # (2) Civil Cover Sheet)(srs) |
